July 2025

Opportunities in Pakistan’s Pharmaceutical Industry

The Pakistan Pharmaceutical Industry is uniquely positioned to address this national pain point. With promising reforms, digital transformation, and investment support, the industry is on a strong growth path. Public-private partnerships and research-driven models offer new hope for both patients and producers. Moreover, the Pakistan Pharmaceutical Manufacturers Association (PPMA) serves as a key body in […]

Opportunities in Pakistan’s Pharmaceutical Industry Read More ยป

๐๐ก๐š๐ซ๐ฆ๐„๐ฑ ๐๐š๐ค๐ข๐ฌ๐ญ๐š๐ง ๐‹๐š๐ฎ๐ง๐œ๐ก๐ž๐ ๐ญ๐จ ๐๐จ๐จ๐ฌ๐ญ ๐„๐ฑ๐ฉ๐จ๐ซ๐ญ๐ฌ

๐๐ก๐š๐ซ๐ฆ๐„๐ฑ ๐๐š๐ค๐ข๐ฌ๐ญ๐š๐ง ๐‹๐š๐ฎ๐ง๐œ๐ก๐ž๐ ๐ญ๐จ ๐๐จ๐จ๐ฌ๐ญ ๐„๐ฑ๐ฉ๐จ๐ซ๐ญ๐ฌ

The government aims to raise pharma exports from $355M to $3B annually with the launch of PharmEx Pakistan. A dedicated Exporter Facilitation Desk will tackle regulatory and market access challenges, accelerating global growth for the industry.

๐๐ก๐š๐ซ๐ฆ๐„๐ฑ ๐๐š๐ค๐ข๐ฌ๐ญ๐š๐ง ๐‹๐š๐ฎ๐ง๐œ๐ก๐ž๐ ๐ญ๐จ ๐๐จ๐จ๐ฌ๐ญ ๐„๐ฑ๐ฉ๐จ๐ซ๐ญ๐ฌ Read More ยป

๐๐ก๐š๐ซ๐ฆ๐š ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐œ๐š๐ฅ๐ฅ๐ฌ ๐Ÿ๐จ๐ซ ๐‘&๐ƒ ๐Ÿ๐ฎ๐ง๐ ๐จ๐ฏ๐ž๐ซ๐ก๐š๐ฎ๐ฅ ๐ญ๐จ ๐๐ซ๐ข๐ฏ๐ž ๐ข๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง

๐๐ก๐š๐ซ๐ฆ๐š ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐œ๐š๐ฅ๐ฅ๐ฌ ๐Ÿ๐จ๐ซ ๐‘&๐ƒ ๐Ÿ๐ฎ๐ง๐ ๐จ๐ฏ๐ž๐ซ๐ก๐š๐ฎ๐ฅ ๐ญ๐จ ๐๐ซ๐ข๐ฏ๐ž ๐ข๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง

The pharmaceutical industry, led by PPMA Chairman Tauqeer Ul Haq, has urged reforms to the Central Research Fund (CRF), proposing that the 1% mandatory contribution be redirected to in-house R&D. This move aims to boost innovation, ensure global regulatory compliance, and reduce bureaucratic inefficiencies.

๐๐ก๐š๐ซ๐ฆ๐š ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐œ๐š๐ฅ๐ฅ๐ฌ ๐Ÿ๐จ๐ซ ๐‘&๐ƒ ๐Ÿ๐ฎ๐ง๐ ๐จ๐ฏ๐ž๐ซ๐ก๐š๐ฎ๐ฅ ๐ญ๐จ ๐๐ซ๐ข๐ฏ๐ž ๐ข๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง Read More ยป

๐ƒ๐‘๐€๐ ๐๐ซ๐จ๐ฉ๐จ๐ฌ๐ž๐ฌ ๐€๐ฆ๐ž๐ง๐๐ฆ๐ž๐ง๐ญ๐ฌ ๐ญ๐จ ๐‹๐š๐›๐ž๐ฅ๐ฅ๐ข๐ง๐  & ๐๐š๐œ๐ค๐ข๐ง๐  ๐‘๐ฎ๐ฅ๐ž๐ฌ

The Drug Regulatory Authority of Pakistan (DRAP) has released draft amendments to the Drugs (Labelling and Packing) Rules, 1986, inviting stakeholder feedback within 7 days. PPMA encourages member companies to review the proposed changes and participate in the consultation process to support regulatory improvement andย patientย safety.

๐ƒ๐‘๐€๐ ๐๐ซ๐จ๐ฉ๐จ๐ฌ๐ž๐ฌ ๐€๐ฆ๐ž๐ง๐๐ฆ๐ž๐ง๐ญ๐ฌ ๐ญ๐จ ๐‹๐š๐›๐ž๐ฅ๐ฅ๐ข๐ง๐  & ๐๐š๐œ๐ค๐ข๐ง๐  ๐‘๐ฎ๐ฅ๐ž๐ฌ Read More ยป